Elevate your local knowledge

Sign up for the iNFOnews newsletter today!

Select Region

Selecting your primary region ensures you get the stories that matter to you first.

Rookie 2B Devon Travis gets another cortisone shot, hopeful of returning to Blue Jays’ lineup

CP34329381
Toronto Blue Jays second baseman Devon Travis fields a ball hit by Kansas City Royals\' Mike Moustakas during the sixth inning of a baseball game at Kauffman Stadium in Kansas City, Mo., on July 11, 2015. Blue Jays rookie second baseman Devon Travis is hopeful of returning to Toronto\'s lineup this season after having another cortisone shot in his injured left shoulder.Travis was examined Tuesday by Rangers team physician Dr. Keith Meister before Toronto opened a three-game series in Texas. THE CANADIAN PRESS/AP, Orlin Wagner

ARLINGTON, Texas – Blue Jays rookie second baseman Devon Travis is hopeful of returning to Toronto’s lineup this season after having another cortisone shot in his injured left shoulder.

Travis was examined Tuesday by Rangers team physician Dr. Keith Meister before Toronto opened a three-game series in Texas.

Travis re-injured his left shoulder July 28 and received a cortisone shot a few days later. He missed 36 games earlier this season after getting hit by a bad-hop grounder April 30 at Cleveland, though he didn’t go on the disabled list for another two weeks after that, and then returned June 26.

In 62 games this season, Travis has hit .304 with eight home runs and 35 RBIs.

The infielder says there is no nerve damage and that Meister told him that there are just some muscles that need more rest.

News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

Join the Conversation!

Want to share your thoughts, add context, or connect with others in your community?

Create a free account

The Associated Press

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.

Related Articles